BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20082478)

  • 21. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia.
    Waki T; Tamura G; Tsuchiya T; Sato K; Nishizuka S; Motoyama T
    Am J Pathol; 2002 Aug; 161(2):399-403. PubMed ID: 12163364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
    Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
    PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
    Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
    Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer.
    Hagiwara T; Sugimoto K; Momose H; Irie T; Honjo K; Okazawa YU; Kawai M; Kawano S; Munakata S; Takahashi M; Kojima Y; Serizawa N; Nagahara A; Hoffman RM; Brock MV; Sakamoto K
    Anticancer Res; 2022 Feb; 42(2):697-707. PubMed ID: 35093868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
    Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
    World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHFR promotes metastasis of human gastric carcinoma by activating AKT and ERK via NRF2- ROS axis.
    He F; Ye B; Wu X; Pan J; Wang J; Wang X
    BMC Gastroenterol; 2023 Apr; 23(1):114. PubMed ID: 37024798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia.
    Honda T; Tamura G; Waki T; Kawata S; Nishizuka S; Motoyama T
    Br J Cancer; 2004 May; 90(10):2013-6. PubMed ID: 15138487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer.
    Cha Y; Kim SY; Yeo HY; Baek JY; Choi MK; Jung KH; Dong SM; Chang HJ
    Neoplasia; 2019 Jan; 21(1):146-155. PubMed ID: 30562637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer.
    Chan AO; Lam SK; Wong BC; Wong WM; Yuen MF; Yeung YH; Hui WM; Rashid A; Kwong YL
    Gut; 2003 Apr; 52(4):502-6. PubMed ID: 12631658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
    Sugita H; Iida S; Inokuchi M; Kato K; Ishiguro M; Ishikawa T; Takagi Y; Enjoji M; Yamada H; Uetake H; Kojima K; Sugihara K
    Oncol Rep; 2011 Feb; 25(2):513-8. PubMed ID: 21152877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma.
    Yamamoto M; Yoshinaga K; Matsuyama A; Tsutsui S; Ishida T
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):607-12. PubMed ID: 24509654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation of CHFR is not a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
    Yoshida K; Hamai Y; Suzuki T; Sanada Y; Oue N; Yasui W
    Anticancer Res; 2006; 26(1A):49-54. PubMed ID: 16475678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.
    Ohzawa H; Saito A; Kumagai Y; Kimura Y; Yamaguchi H; Hosoya Y; Lefor AK; Sata N; Kitayama J
    Oncol Rep; 2020 Apr; 43(4):1081-1088. PubMed ID: 32323853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer.
    Abe N; Watanabe T; Toda H; Machida H; Suzuki K; Masaki T; Mori T; Sugiyama M; Atomi Y; Nakaya Y
    Am J Surg; 2001 Apr; 181(4):356-61. PubMed ID: 11438272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer.
    Togano S; Yashiro M; Miki Y; Yamamoto Y; Sera T; Kushitani Y; Sugimoto A; Kushiyama S; Nishimura S; Kuroda K; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Tanaka S; Ohira M
    PLoS One; 2020; 15(1):e0225958. PubMed ID: 31940352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Sato S; Miyazaki K
    J Gastroenterol; 2006 Feb; 41(2):133-9. PubMed ID: 16568372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis for the combination expression of CK20, FABP1 and MUC2 is sensitive for the prediction of peritoneal recurrence in gastric cancer.
    Satoh Y; Mori K; Kitano K; Kitayama J; Yokota H; Sasaki H; Uozaki H; Fukayama M; Seto Y; Nagawa H; Yatomi Y; Takai D
    Jpn J Clin Oncol; 2012 Feb; 42(2):148-52. PubMed ID: 22172348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF significance in peritoneal recurrence from gastric cancer.
    Aoyagi K; Kouhuji K; Yano S; Miyagi M; Imaizumi T; Takeda J; Shirouzu K
    Gastric Cancer; 2005; 8(3):155-63. PubMed ID: 16086118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.
    Tanaka M; Chang P; Li Y; Li D; Overman M; Maru DM; Sethi S; Phillips J; Bland GL; Abbruzzese JL; Eng C
    Clin Cancer Res; 2011 Jul; 17(13):4531-40. PubMed ID: 21551253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.